Jim Simons Protalix Bio Therapeutics, Inc. Transaction History
Renaissance Technologies LLC
- $56.7 Billion
- Q2 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Protalix Bio Therapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 804,600 shares of PLX stock, worth $844,830. This represents 0.0% of its overall portfolio holdings.
Number of Shares
804,600
Previous 824,700
2.44%
Holding current value
$844,830
Previous $1.04 Million
9.43%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding PLX
# of Institutions
70Shares Held
5.61MCall Options Held
103KPut Options Held
4.6K-
Israel Englander Millennium Management LLC | New York, Ny811KShares$851,7180.0% of portfolio
-
Goldman Sachs Group Inc New York, NY462KShares$485,0550.0% of portfolio
-
Northern Trust Corp Chicago, IL423KShares$444,3730.0% of portfolio
-
Gsa Capital Partners LLP London, X0401KShares$421,3060.03% of portfolio
-
Black Rock Inc. New York, NY333KShares$349,8290.0% of portfolio
About Protalix BioTherapeutics, Inc.
- Ticker PLX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,753,400
- Market Cap $52.2M
- Description
- Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...